Cargando…

Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial

Luminal, human epidermal growth factor receptor 2–negative breast cancer represents the most common subtype of breast malignancies. Neoadjuvant strategies of operable breast cancer are mostly based on chemotherapy, whereas it is not completely understood which patients might benefit from neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlSaleh, Khalid, Al Zahwahry, Heba, Bounedjar, Adda, Oukkal, Mohammed, Saadeddine, Ahmed, Mahfouf, Hassen, Bouzid, Kamel, Bensalem, Assia, Filali, Taha, Abdel-Razeq, Hikmat, Larbaoui, Blaha, Kandil, Alaa, Abulkhair, Omalkhair, Al Foheidi, Meteb, Errihani, Hassan, Ghosn, Marwan, Abdel-Aziz, Nashwa, Arafah, Maria, Boussen, Hamouda, Dabouz, Farida, Rasool, Haleem, Bahadoor, Mohun, Ayari, Jihen, Kullab, Sharif, Nabholtz, Jean-Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2021
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457874/ https://www.ncbi.nlm.nih.gov/pubmed/34086481 http://dx.doi.org/10.1200/GO.20.00575

Ejemplares similares

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial
por: Alsaleh, K., et al.
Publicado: (2023)

Breast-cancer detection using blood-based infrared molecular fingerprints
por: Kepesidis, Kosmas V., et al.
Publicado: (2021)

Middle East and North Africa Registry to Characterize Rate of RAS Testing Status in Newly Diagnosed Patients with Metastatic Colorectal Cancer
por: Oukkal, Mohammed, et al.
Publicado: (2023)

Efficacy and safety of second-generation CAR T-cell therapy in diffuse large B-cell lymphoma: A meta-analysis
por: Al-Mansour, Mubarak, et al.
Publicado: (2020)

Granulocyte Colony Stimulating Factor (G-CSF) Induced Splenic Infarction in Breast Cancer Patient Treated with Dose-Dense Chemotherapy Regimen
por: Alshamrani, Majed A., et al.
Publicado: (2019)

Energy and caloric restriction, and fasting and cancer: a narrative review
por: Ibrahim, Ezzeldin M., et al.
Publicado: (2020)

Delayed Paclitaxel-Trastuzumab-Induced Interstitial Pneumonitis in Breast Cancer
por: Abulkhair, Omalkhair, et al.
Publicado: (2011)

Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis
por: Ibrahim, Ezzeldin M, et al.
Publicado: (2012)

The first national public breast cancer screening program in Saudi Arabia
por: Abulkhair, Omalkhair A., et al.
Publicado: (2010)

Breast Cancer Patients’ Perceptions of Their Experience With Chemotherapy-Induced Nausea and Vomiting and Its Impact on Quality of Life in Jeddah, Saudi Arabia
por: Ilyas, Ahmed B, et al.
Publicado: (2020)

Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer
por: Abulkhair, Omalkhair, et al.
Publicado: (2018)

Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer
por: Marie, Lina, et al.
Publicado: (2022)

Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review
por: Sharaf, Baha', et al.
Publicado: (2022)

Urinary bladder metastasis from primary breast cancer, a rare and challenging diagnosis. A case report and literature review
por: Abdel-Razeq, Rashid, et al.
Publicado: (2022)

OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma
por: Ghosn, Marwan, et al.
Publicado: (2019)

Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2018)

The Level of Agreement Among Medical Oncologists on Adjuvant Chemotherapy Decision for Breast Cancer in Pre and Post-Oncotype DX Settings
por: Alkushi, Abdulmohsen, et al.
Publicado: (2021)

The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients
por: Souan, Lina, et al.
Publicado: (2023)

Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country
por: Al-Tabba', Amal, et al.
Publicado: (2020)

Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve
por: Abdel-Razeq, Hikmat
Publicado: (2010)

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
por: Abdel-Razeq, Hikmat
Publicado: (2016)

Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
por: Abdel-Razeq, Hikmat
Publicado: (2019)

The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers
por: Abdel-Razeq, Hikmat
Publicado: (2017)

Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer
por: Abdel-Razeq, Hikmat
Publicado: (2019)

Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!
por: Abdel-Razeq, Hikmat
Publicado: (2021)

Surgical options for patients with early-stage breast cancer and pathogenic germline variants: an oncologist perspectives
por: Abdel-Razeq, Hikmat
Publicado: (2023)

Complete and Durable Response to Tamoxifen and Ovarian Ablation in the Treatment of Metastatic Breast Cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Prolonged Neutropenia and Yellowish Discoloration of the Skin, But Not the Sclera, Following Excessive Turmeric Raw Root Ingestion
por: Abdel-Razeq, Rashid, et al.
Publicado: (2021)

Assessing the Correlation of Rate of Pathological Complete Response and Outcome in Post Neoadjuvant Chemotherapy Setting and Molecular Subtypes of Breast Cancer
por: Omair, Ahmad, et al.
Publicado: (2023)

Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer
por: Elghazaly, Hesham, et al.
Publicado: (2021)

Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Aggressiveness of Cancer Care at End of Life in Patients with Metastatic Breast Cancer in Jordan
por: Abunasser, Mahmoud, et al.
Publicado: (2023)

Metaplastic Breast Carcinoma: Experience of a Tertiary Cancer Center in the Middle East
por: Erjan, Ayah, et al.
Publicado: (2021)

Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Differences in clinicopathological characteristics, treatment, and survival outcomes between older and younger breast cancer patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study
por: Souan, Lina, et al.
Publicado: (2023)

Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2011)

Current neoadjuvant treatment options for HER2-positive breast cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ggjgvbpnvjbljnlodfk57d1mss